Policy on Cross-Shareholdings and Standards for Exercising Voting Rights

Policy on Cross-Shareholdings

Fuji holds shares of other companies for seeking to establish and strengthen business relationships that contribute towards the expansion and development of business as well as stability and efficiency. It is our policy to make a comprehensive judgment on whether the holding of individual stocks is rational and appropriate while assessing the level of the Fuji's cost of capital and the level of ROE of the target companies from the perspective of capital efficiency. Every year, the Board of Directors reviews and confirms the appropriateness of each holding, taking into account its relationship with Fuji's business and its contribution to the future direction of Fuji's business. During the period of the mid-term business plan, which began in FY2025 and ends in FY2027, we will generate 7 billion yen through measures such as reducing cross-shareholdings and allocate it to growth investments and returns to shareholders.By the end of March 2026, we had generated 8 billion yen by reducing our strategic equity holdings, and we will continue to reduce these holdings.

Status of cross-shareholdings
  March 31, 2022March 31, 2023March 31, 2024March 31, 2025March 31, 2026
Number of holdingsListed2926252320
Unlisted66666
Total3532312926
Carrying amount on the balance sheet
(millions of yen)
Listed18,45817,78423,58817,87818,762
Unlisted3535353535
Total18,49317,82023,62317,91418,797
Net assets (millions of yen)208,782225,104228,278218,682232,454
Ratio8.90%7.90%10.30%8.20%8.08%
Total amount of sales associated with reductions in shareholdings
(millions of yen)
3,2902,0794463,1304,930

Basic Views on Exercise of Voting Rights

In exercising the voting rights as to cross-shareholdings, the Company does not make decisions in accordance with uniform standards. Rather, the Company assesses whether its decisions on the agenda would deteriorate the delivery of potential values to shareholders. Taking into account the business conditions of the issuer companies and other matters in the circumstances, the Company makes approval or disapproval decisions and exercises the vote rights.

innovative story

Facing challenges drives the future.
DNA that never stops evolving.
Human stories woven through technology.